Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review.
Maryam GolmohammadiMohammad Yassin ZamanianAhmed Muzahem Al-AniThaer L JabbarAli Kamil KareemZeinab Hashem AghaeiHossein TaherniaAhmed HjaziSaad Abdul-Ridh JissirElham HakimizadehPublished in: Animal models and experimental medicine (2024)
CUR and its analogues hold promise as effective adjuvant treatments for BC by targeting the STAT3 signaling pathway. These compounds provide new insights into the mechanisms of action of CUR and its potential to enhance the effectiveness of BC therapies.